Morgan & Morgan’s Michael Goetz Named to Plaintiffs’ Steering Committee for Byetta, Januvia MDL

The Honorable Judge Anthony J. Battaglia has selected Michael Goetz, the head of Morgan & Morgan’s mass tort section, to the plaintiffs’ steering committee for the multidistrict litigation involving Type 2 diabetes drugs Byetta, Januvia, Janumet, and Victoza.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friendRepost This
It is a privilege that the Honorable Judge Battaglia selected me as part of the plaintiffs’ steering committee to help patients and their loved ones move forward with their claims.

Tampa, FL (PRWEB) November 01, 2013

Morgan & Morgan is proud to announce that attorney Michael Goetz, head of the firm’s mass tort section, has been selected to the plaintiffs’ steering committee for the multidistrict litigation (MDL) involving Type 2 diabetes drugs Byetta, Januvia, Janumet, and Victoza. The MDL alleges use of one or more of the drugs can cause pancreatic cancer, according to court documents.

“It is a privilege that the Honorable Judge Battaglia selected me as part of the plaintiffs’ steering committee to help patients and their loved ones move forward with their claims,” Goetz said. “Any progress made in this case is a step in the right direction, a step towards accountability.”

In August 2013, the U.S. Judicial Panel on Multidistrict Litigation (JPML) consolidated all federally-filed suits involving the diabetes drugs to the U.S. District Court for the Southern District of California. According to court documents, the plaintiffs in the actions each allege use of one or more of the four drugs caused them or their decedent to develop pancreatic cancer.

Although the JPML is “typically hesitant to centralize litigation against multiple, competing defendants which marketed, manufactured and sold similar products,” according to court records, the panel found the plaintiffs made “highly similar allegations” regarding the four drugs’ management of insulin levels and their alleged predisposition to cause pancreatic cancer. Furthermore, court documents state several plaintiffs took more than one of the drugs, suggesting that “discovery specific to the plaintiffs in those cases will involve many of the same or substantially similar documents and witnesses.”

“We expect to prove that taking these drugs creates a heightened risk of developing pancreatic cancer that doctors and patients were not warned about,” Goetz said. “My goal as part of the plaintiff’s steering committee is to not only work in the best interests of each plaintiff, but to find out exactly what these drug manufacturers knew in connection with the risks posed by their products.”

Goetz and his team of attorneys at Morgan & Morgan continue to offer free case evaluations to patients prescribed Jaumet, Januvia, Byetta, and/or Victoza who have been diagnosed with pancreatic cancer, as well as loved ones acting on their behalf. For more information and to fill out a free, no risk case review form, please visit http://www.ForThePeople.com/class-action-lawyers today.

About Morgan & Morgan

Morgan & Morgan is one of the largest exclusively plaintiffs’ law firms in the country with 17 offices throughout Florida, Georgia, Mississippi, Tennessee, Kentucky, and New York. The firm handles cases nationally involving personal injury, medical malpractice, consumer class action, and securities fraud, as well as complex litigation against drug and medical device manufacturers. Visit Morgan & Morgan online at http://www.forthepeople.com/ for a free case evaluation and information about your legal rights.

*MDL Case No. 13md2452 AJB (MDD), in RE: Incretin Mimetics Products Liability Litigation, United


Contact